Publication | Closed Access
S114. Efficacy and Safety of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression
17
Citations
0
References
2018
Year
Psychoactive DrugPsychiatryElderly PatientsIntranasal Esketamine PlusPsychotropic MedicationPharmacologyPsychopharmacologyDepressionSocial SciencesPharmacotherapyMental HealthMedicinePsychopathologyTreatment-resistant Depression
No additional data available for this publication yet. Check back later!